ArticleHealth science reports2025
Analysis and Mapping of Machine Learning in the Context of Diabetes.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The application of machine learning (ML) has started to change some important aspects of health care in diabetes. We aimed to utilize a bibliometric approach to analyze and map ML in the context of diabetes. Methods: To build our data set, we searched from the Web of Science Core Collection (WoSCC) database, and restricted our search from January 1, 2010 to December 31, 2023. For citation analysis, the online services of WoS were used to investigate the information content of the data set, VOSviewer and Microsoft Excel 2013 were employed to construct and visualize the bibliographic data. Results: Overall, 5,222 results that met the criteria were retrieved. The trend of published studies indicates that the number of publications has steadily increased over the past 14 years. The most active country was found to be USA, followed by the China and India. The highest level of cooperation with other countries belonged to the USA. The most prolific author on ML in the context of diabetes was Tien Yin Wong, with twenty-two articles affiliated at Tsinghua University; after that, Pantelis Georgiou with twenty articles affiliated at the Imperial College London, and Pau Herrero, with nineteen articles affiliated at Tijuana Institute of Technology. The most prolific research areas were machine learning, prediction models, diabetic retinopathy, deep learning, and diagnostics. Conclusion: The results of this study are a rich scientific source of ML for diabetes to guide researchers. This study can guide policymakers, physicians, and practitioners to help in the decision-making process. In addition, the findings will be useful for governments to guide future budgets for target studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.